Advanced Life Sciences Financial Statements
Advanced Life Sciences Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Advanced Life Sciences Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 0.0 | 0.0 | 0.1 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (32.6) | (22.6) | (6.2) |
| Total Net Income ($ mil.) | (32.3) | (20.5) | (6.4) |
| Diluted EPS (Net Income) | (1.12) | (0.78) | -- |
Advanced Life Sciences Quarterly Statements
| Quarter Ending Jun 08 | Quarter Ending Mar 08 | Quarter Ending Dec 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 0.0 | 0.0 | 0.0 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (3.4) | (3.6) | (5.5) |
| Total Net Income ($ mil.) | (3.4) | (3.5) | (5.5) |
| Diluted EPS (Net Income) | (0.09) | (0.09) | (0.17) |
Advanced Life Sciences Stock Quote & Chart
10/06/08 15:00:09 EST •
NASDAQ •
0.53
•
 -0.1600
•
-23.1884 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Advanced Life Sciences Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | -- | 3.69 | 1.54 |
| Price/Earnings Ratio | -- | 15.22 | 15.51 |
| Price/Book Ratio | 8.31 | 2.94 | 1.48 |
| Price/Cash Flow Ratio | -- | 12.49 | 9.68 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Advanced Life Sciences Financial Ratios
Advanced Life Sciences Competitive Intelligence
| GlaxoSmithKline | Johnson & Johnson | Pfizer | |
|---|---|---|---|
| Annual Sales ($ mil.) | 22,716.0 | 61,095.0 | 48,418.0 |
| Employees | 103,401 | 119,200 | 86,600 |
| Market Cap ($ mil.) | -- | 198,797.7 | 129,966.4 |
Competitive Landscape
